Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

10 small-cap stocks selected by digging deep for quality

David Trainer explains how New Constructs incorporates decades of information buried in companies’ financial statement notes, for “better” calculations of returns on invested capital

Business - MarketWatch - October 19

Jim Cramer's top 10 things to watch in the stock market Friday

Stocks were set for a higher open, and the FTC picked up a big win in court.

Business - CNBC - 5 days ago

Jim Cramer's top 10 things to watch in the stock market Tuesday

Stocks were headed for a muted open after a solid session Monday.

Business - CNBC - Yesterday

Top 10 things to watch in the stock market Thursday, including news on Nvidia, 3 other Club stocks

The S&P 500 was trying to break a three-session losing streak.

Business - CNBC - 6 days ago

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - 6 days ago

Pogba: 'Anger' will make me better after drug ban

Paul Pogba has warned he will return to football "even better" from his ban for taking a prohibited substance, stating that he is driven by "anger" at his absence.

Sports - ESPN - October 16

Tesla shares jump on profit beat, Musk's prediction of at least 20% 'vehicle growth' next year

Tesla reported better-than-expected profit in its third-quarter earnings report on Wednesday.

Business - CNBC - 6 days ago

Goldman Sachs beats on profit and revenue as stock trading and investment banking boost results

Wall Street trading and investment banking has helped the big banks this quarter, and Goldman Sachs results showed why they are a leader in those areas.

Business - CNBC - October 15

3M’s stock turns red as profit beat, but retail customers are still holding back

The maker of Post-it Notes saw it’s stock surge to a multi-year high, then pull a sharp U-turn into the red, even as earnings beat expectations.

Business - MarketWatch - October 22

We're trimming a bank stock on tear since earnings, booking nearly a 100% profit

This sale does not reflect any change in our long-standing positive view on the bank and the job the CEO is doing.